170 related articles for article (PubMed ID: 35052404)
1. HIV Protease and Integrase Empirical Substitution Models of Evolution: Protein-Specific Models Outperform Generalist Models.
Del Amparo R; Arenas M
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052404
[TBL] [Abstract][Full Text] [Related]
2. A combined empirical and mechanistic codon model.
Doron-Faigenboim A; Pupko T
Mol Biol Evol; 2007 Feb; 24(2):388-97. PubMed ID: 17110464
[TBL] [Abstract][Full Text] [Related]
3. Protein promiscuity: drug resistance and native functions--HIV-1 case.
Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
[TBL] [Abstract][Full Text] [Related]
4. Lack of evidence for protease evolution in HIV-1-infected patients after 2 years of successful highly active antiretroviral therapy.
Parera M; Ibañez A; Clotet B; Martinez MA
J Infect Dis; 2004 Apr; 189(8):1444-51. PubMed ID: 15073682
[TBL] [Abstract][Full Text] [Related]
5. Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors.
Meixenberger K; Yousef KP; Smith MR; Somogyi S; Fiedler S; Bartmeyer B; Hamouda O; Bannert N; von Kleist M; Kücherer C
Virol J; 2017 Nov; 14(1):223. PubMed ID: 29137637
[TBL] [Abstract][Full Text] [Related]
6. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
[TBL] [Abstract][Full Text] [Related]
7. Identification of biased amino acid substitution patterns in human immunodeficiency virus type 1 isolates from patients treated with protease inhibitors.
Shafer RW; Hsu P; Patick AK; Craig C; Brendel V
J Virol; 1999 Jul; 73(7):6197-202. PubMed ID: 10364383
[TBL] [Abstract][Full Text] [Related]
8. Substitution Models of Protein Evolution with Selection on Enzymatic Activity.
Ferreiro D; Khalil R; Sousa SF; Arenas M
Mol Biol Evol; 2024 Feb; 41(2):. PubMed ID: 38314876
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase.
Quashie PK; Oliviera M; Veres T; Osman N; Han YS; Hassounah S; Lie Y; Huang W; Mesplède T; Wainberg MA
J Virol; 2015 Mar; 89(6):3163-75. PubMed ID: 25552724
[TBL] [Abstract][Full Text] [Related]
10. Influence of substitution model selection on protein phylogenetic tree reconstruction.
Del Amparo R; Arenas M
Gene; 2023 May; 865():147336. PubMed ID: 36871672
[TBL] [Abstract][Full Text] [Related]
11. Parallel evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selection.
Crandall KA; Kelsey CR; Imamichi H; Lane HC; Salzman NP
Mol Biol Evol; 1999 Mar; 16(3):372-82. PubMed ID: 10331263
[TBL] [Abstract][Full Text] [Related]
12. A class frequency mixture model that adjusts for site-specific amino acid frequencies and improves inference of protein phylogeny.
Wang HC; Li K; Susko E; Roger AJ
BMC Evol Biol; 2008 Dec; 8():331. PubMed ID: 19087270
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 subtype G and BG recombinant viruses in Spanish natives: evidence of characteristic mutations in reverse transcriptase and protease.
Pérez-Alvarez L; Thomson MM; Villahermosa ML; de Parga EV; Rodríguez A; Cuevas MT; Delgado E; Manjón N; Miralles C; Medrano L; Taboada JA; Nájera R
AIDS; 2001 Sep; 15(14):1907-10. PubMed ID: 11579264
[No Abstract] [Full Text] [Related]
14. Genotypic prediction of resistant mutation in HIV-1 pol gene towards the antiretroviral drugs.
Kumar A; Jadhav C
Int J Bioinform Res Appl; 2011; 7(1):15-23. PubMed ID: 21441094
[TBL] [Abstract][Full Text] [Related]
15. Reverse transcriptase and protease sequence evolution in two HIV-1-infected couples.
Palmer S; Vuitton D; Gonzales MJ; Bassignot A; Shafer RW
J Acquir Immune Defic Syndr; 2002 Nov; 31(3):285-90. PubMed ID: 12439203
[TBL] [Abstract][Full Text] [Related]
16. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.
Pariente N; Pernas M; de la Rosa R; Gómez-Mariano G; Fernández G; Rubio A; López M; Benito JM; López-Galíndez C; Leal M; Domingo E; Martinez MA; Mas A
J Med Virol; 2004 Jul; 73(3):350-61. PubMed ID: 15170628
[TBL] [Abstract][Full Text] [Related]
17. An amino acid substitution-selection model adjusts residue fitness to improve phylogenetic estimation.
Wang HC; Susko E; Roger AJ
Mol Biol Evol; 2014 Apr; 31(4):779-92. PubMed ID: 24441033
[TBL] [Abstract][Full Text] [Related]
18. Indinavir resistance evolution: a comment.
Wiwanitkit V
Virol Sin; 2011 Feb; 26(1):72. PubMed ID: 21331894
[No Abstract] [Full Text] [Related]
19. Protease gene analysis of HIV type 1 non-B subtypes in Spain.
Holguín A; Rodés B; Soriano V
AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1395-403. PubMed ID: 11018859
[TBL] [Abstract][Full Text] [Related]
20. Comparison of protease genotype and phenotype in HIV-1 infected patients exposed to more than one protease inhibitor.
Gianotti N; Tambussi G; Boeri E; Lazzarin A
J Biol Regul Homeost Agents; 2001; 15(2):166-9. PubMed ID: 11501975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
